Research Nester published a report titled “Automated Cell Culture Market: Global Demand Analysis & Opportunity Outlook 2031” which delivers detailed overview of the global automated cell culture market in terms of market segmentation by product, application, end-user, and by region.
Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.
The global automated cell culture market is anticipated to grow with a CAGR of 8.7% over the forecast period, i.e., 2022 – 2031. The market is segmented by application into biopharmaceutical production, tissue engineering & regenerative medicine, drug screening & development, gene therapy, stem cell research, diagnostics, toxicity testing, and others. Out of these, the biopharmaceutical production segment is anticipated to garner the largest revenue of USD 5870.5 Million by the end of 2031. Further, in the year 2021, the segment generated a revenue of USD 2526.3 Million.
The global automated cell culture market is estimated to garner a revenue of USD 26411.9 Million by the end of 2031, up from a revenue of USD 11506.8 Million in the year 2021. Growing research and development activities in the field of medical science, followed by the high efficiency and lack of error associated with the use of automated cell culture processes are some of the major factors anticipated to drive the growth of the market in the coming years.
Geographically, the global automated cell culture market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Out of these, the market in North America is projected to garner the largest revenue of USD 11542.0 Million by the end of 2031. Additionally, in the year 2021, the market in the region generated a revenue of USD 5104.0 Million.
The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.
Surge in Concern for the Prevalence of Chronic and Infectious Diseases to Drive Market Growth
Each year 41 Million people are known to die due to noncommunicable diseases (NCDs), according to the statistics by the World Health Organization.
Backed by the surge in concern for the prevalence of different types of diseases, there is a growing need amongst the healthcare providers for advanced medicines that can help to treat the patients suffering from these chronic diseases. On the other hand, the drug manufacturers are in need for advanced processes that can help them lower manufacturing error and also enhance process efficiency. With the help of automated cell culture processes, such factors can be easily achieved, which is therefore promoting the adoption of the manufacturing process amongst the pharmaceutical drug manufacturers. Such a factor is therefore anticipated to drive the growth of the global automated cell culture market.
However, the higher cost associated with the use of the cell culture process is expected to operate as key restraint to the growth of global automated cell culture market over the forecast period.
This report also provides the existing competitive scenario of some of the key players of the global automated cell culture market which includes company profiling of Hitachi, Ltd., Thermo Fisher Scientific, Inc., Sartorius AG, Hamilton Company, F. Hoffmann-La Roche Ltd., Merck KGaA, Becton, Dickinson and Company, Cell Culture Company, LLC, Lonza Group, and others. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global automated cell culture market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.